Market cap of Thermo Fisher Scientific Inc. [TMO] reaches 230.41B – now what?



Thermo Fisher Scientific Inc. [NYSE: TMO] price surged by 7.38 percent to reach at $38.41. The company report on April 28, 2022 that Thermo Fisher Scientific Reports First Quarter 2022 Results.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2022.

A sum of 2733997 shares traded at recent session while its average daily volume was at 1.53M shares. Thermo Fisher Scientific Inc. shares reached a high of $567.33 and dropped to a low of $548.10 until finishing in the latest session at $558.89.

The one-year TMO stock forecast points to a potential upside of 18.34. The average equity rating for TMO stock is currently 1.80, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Thermo Fisher Scientific Inc. [TMO]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TMO shares is $684.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TMO stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for Thermo Fisher Scientific Inc. shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on April 25, 2022. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on January 26, 2022, representing the official price target for Thermo Fisher Scientific Inc. stock. Previously, the target price had yet another raise from $620 to $700, while Citigroup kept a Buy rating on TMO stock. On October 15, 2021, analysts increased their price target for TMO shares from 655 to 696.

The Average True Range (ATR) for Thermo Fisher Scientific Inc. is set at 18.76, with the Price to Sales ratio for TMO stock in the period of the last 12 months amounting to 5.88. The Price to Book ratio for the last quarter was 5.40. Price to Free Cash Flow for TMO in the course of the last twelve months was 36.04 with Quick ratio for the last quarter at 1.10.

TMO Stock Performance Analysis:

Thermo Fisher Scientific Inc. [TMO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.71. With this latest performance, TMO shares dropped by -5.73% in over the last four-week period, additionally sinking by -8.72% over the last 6 months – not to mention a rise of 20.35% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TMO stock in for the last two-week period is set at 47.55, with the RSI for the last a single of trading hit 48.35, and the three-weeks RSI is set at 47.57 for Thermo Fisher Scientific Inc. [TMO]. The present Moving Average for the last 50 days of trading for this stock 563.10, while it was recorded at 540.25 for the last single week of trading, and 584.80 for the last 200 days.

Insight into Thermo Fisher Scientific Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Thermo Fisher Scientific Inc. [TMO] shares currently have an operating margin of +26.31 and a Gross Margin at +50.07. Thermo Fisher Scientific Inc.’s Net Margin is presently recorded at +19.70.

Return on Equity for this stock inclined to 20.52, with Return on Assets sitting at 9.41.

Thermo Fisher Scientific Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.50.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TMO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Thermo Fisher Scientific Inc. go to 9.13%.

Thermo Fisher Scientific Inc. [TMO] Insider Position Details

There are presently around $194,021 million, or 90.60% of TMO stock, in the hands of institutional investors. The top three institutional holders of TMO stocks are: VANGUARD GROUP INC with ownership of 31,103,788, which is approximately 0.444% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 30,982,611 shares of the stock with an approximate value of $17.32 billion in TMO stocks shares; and STATE STREET CORP, currently with $9.07 billion in TMO stock with ownership of nearly 3.375% of the company’s market capitalization.

Positions in Thermo Fisher Scientific Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 1,114 institutional holders increased their position in Thermo Fisher Scientific Inc. [NYSE:TMO] by around 12,276,268 shares. Additionally, 967 investors decreased positions by around 12,560,657 shares, while 337 investors held positions by with 322,318,142 shares. The mentioned changes placed institutional holdings at 347,155,067 shares, according to the latest SEC report filing. TMO stock had 236 new institutional investments in for a total of 1,736,028 shares, while 113 institutional investors sold positions of 1,465,564 shares during the same period.